Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · IEX Real-Time Price · USD
22.27
-0.52 (-2.28%)
Dec 29, 2023, 4:00 PM EST - Market closed
Agios Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 4 stock analysts, the average 12-month stock price forecast for AGIO stock stock is $35.75, which predicts an increase of 60.53%. The lowest target is $28 and the highest is $42. On average, analysts rate AGIO stock stock as a buy.
Analyst Consensus: Buy
* Price targets were last updated on Nov 3, 2023.
Analyst Ratings
The average analyst rating for AGIO stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '23 | Aug '23 | Sep '23 | Oct '23 | Nov '23 | Dec '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 3 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold Maintains $32 → $28 | Hold | Maintains | $32 → $28 | +25.73% | Nov 3, 2023 |
| JP Morgan | JP Morgan | Hold Maintains $33 → $32 | Hold | Maintains | $33 → $32 | +43.69% | Aug 7, 2023 |
| RBC Capital | RBC Capital | Buy Maintains $40 → $42 | Buy | Maintains | $40 → $42 | +88.59% | Jun 27, 2023 |
| Piper Sandler | Piper Sandler | Buy Initiates $41 | Buy | Initiates | $41 | +84.10% | Feb 3, 2023 |
| JP Morgan | JP Morgan | Hold Maintains $48 → $33 | Hold | Maintains | $48 → $33 | +48.18% | Dec 1, 2022 |
Financial Forecast
Revenue This Year
28.32M
from 14.24M
Increased by 98.86%
Revenue Next Year
76.12M
from 28.32M
Increased by 168.81%
EPS This Year
-6.35
from -4.23
EPS Next Year
-5.13
from -6.35
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | 29.8M | 247.8M | 168.8M | 365.9M | 684.5M | 997.5M |
| Avg | 28.3M | 76.1M | 117.4M | 249.2M | 483.0M | 635.2M |
| Low | 26.5M | 39.5M | 90.2M | 152.4M | 205.4M | 266.8M |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | 109.3% | 775.1% | 121.8% | 211.7% | 174.7% | 106.5% |
| Avg | 98.9% | 168.8% | 54.2% | 112.2% | 93.8% | 31.5% |
| Low | 85.8% | 39.5% | 18.4% | 29.8% | -17.6% | -44.8% |
EPS Forecast
| EPS | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | -6.42 | -2.79 | -4.13 | -4.32 | 0.79 | 5.57 |
| Avg | -6.35 | -5.13 | -6.26 | -4.61 | 0.44 | 2.60 |
| Low | -6.25 | -7.18 | -8.84 | -4.86 | 0.11 | -0.21 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | - | - | - | - | - | 1,168.8% |
| Avg | - | - | - | - | - | 491.9% |
| Low | - | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.